Aldeyra Therapeutics Submits New Drug Application to the FDA for Reproxalap for the Treatment of Signs and Symptoms of Dry Eye Disease Read more
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy Read more
European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy for the Treatment of HIV in Pediatric Populations Read more
C4XD signs exclusive global licence worth up to $402 million with AstraZeneca for the development and commercialisation of NRF2 Activator programme Read more
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline Read more